MicroRNA-21 Knockout Exacerbates Angiotensin II–Induced Thoracic Aortic Aneurysm and Dissection in Mice With Abnormal Transforming Growth Factor-β–SMAD3 Signaling. Issue 5 (May 2018)
- Record Type:
- Journal Article
- Title:
- MicroRNA-21 Knockout Exacerbates Angiotensin II–Induced Thoracic Aortic Aneurysm and Dissection in Mice With Abnormal Transforming Growth Factor-β–SMAD3 Signaling. Issue 5 (May 2018)
- Main Title:
- MicroRNA-21 Knockout Exacerbates Angiotensin II–Induced Thoracic Aortic Aneurysm and Dissection in Mice With Abnormal Transforming Growth Factor-β–SMAD3 Signaling
- Authors:
- Huang, Xiaofan
Yue, Zhang
Wu, Jia
Chen, Jiuling
Wang, Sihua
Wu, Jie
Ren, Linyun
Zhang, Anchen
Deng, Peng
Wang, Ke
Wu, Chuangyan
Ding, Xiangchao
Ye, Ping
Xia, Jiahong - Abstract:
- Abstract : Objective—: Thoracic aortic aneurysm and dissection (TAAD) are severe vascular conditions. Dysfunctional transforming growth factor-β (TGF-β) signaling in vascular smooth muscle cells and elevated angiotensin II (AngII) levels are implicated in the development of TAAD. In this study, we investigated whether these 2 factors lead to TAAD in a mouse model and explored the possibility of using microRNA-21 ( miR-21 ) for the treatment of TAAD. Approach and Results—: TAAD was developed in Smad3 (mothers against decapentaplegic homolog 3) heterozygous (S3 +/− ) mice infused with AngII. We found that p-ERK (phosphorylated extracellular regulated protein kinases)– and p-JNK (phosphorylated c-Jun N-terminal kinase)–associated miR-21 was higher in TAAD lesions. We hypothesize that downregulation of miR-21 mitigate TAAD formation. However, Smad3 +/− :miR-21 −/− (S3 +/− 21 −/− ) mice exhibited conspicuous TAAD formation after AngII infusion. The vascular wall was dilated, and aortic rupture occurred within 23 days during AngII infusion. We then examined canonical and noncanonical TGF-β signaling and found that miR-21 knockout in S3 +/− mice increased SMAD7 and suppressed canonical TGF-β signaling. Vascular smooth muscle cells lacking TGF-β signals tended to switch from a contractile to a synthetic phenotype. The silencing of Smad7 with lentivirus prevented AngII-induced TAAD formation in S3 +/− 21 −/− mice. Conclusions—: Our study demonstrated that miR-21 knockout exacerbatedAbstract : Objective—: Thoracic aortic aneurysm and dissection (TAAD) are severe vascular conditions. Dysfunctional transforming growth factor-β (TGF-β) signaling in vascular smooth muscle cells and elevated angiotensin II (AngII) levels are implicated in the development of TAAD. In this study, we investigated whether these 2 factors lead to TAAD in a mouse model and explored the possibility of using microRNA-21 ( miR-21 ) for the treatment of TAAD. Approach and Results—: TAAD was developed in Smad3 (mothers against decapentaplegic homolog 3) heterozygous (S3 +/− ) mice infused with AngII. We found that p-ERK (phosphorylated extracellular regulated protein kinases)– and p-JNK (phosphorylated c-Jun N-terminal kinase)–associated miR-21 was higher in TAAD lesions. We hypothesize that downregulation of miR-21 mitigate TAAD formation. However, Smad3 +/− :miR-21 −/− (S3 +/− 21 −/− ) mice exhibited conspicuous TAAD formation after AngII infusion. The vascular wall was dilated, and aortic rupture occurred within 23 days during AngII infusion. We then examined canonical and noncanonical TGF-β signaling and found that miR-21 knockout in S3 +/− mice increased SMAD7 and suppressed canonical TGF-β signaling. Vascular smooth muscle cells lacking TGF-β signals tended to switch from a contractile to a synthetic phenotype. The silencing of Smad7 with lentivirus prevented AngII-induced TAAD formation in S3 +/− 21 −/− mice. Conclusions—: Our study demonstrated that miR-21 knockout exacerbated AngII-induced TAAD formation in mice, which was associated with TGF-β signaling dysfunction. Therapeutic strategies targeting TAAD should consider unexpected side effects associated with alterations in TGF-β signaling. Abstract : Supplemental Digital Content is available in the text. … (more)
- Is Part Of:
- Arteriosclerosis, thrombosis, and vascular biology. Volume 38:Issue 5(2018)
- Journal:
- Arteriosclerosis, thrombosis, and vascular biology
- Issue:
- Volume 38:Issue 5(2018)
- Issue Display:
- Volume 38, Issue 5 (2018)
- Year:
- 2018
- Volume:
- 38
- Issue:
- 5
- Issue Sort Value:
- 2018-0038-0005-0000
- Page Start:
- Page End:
- Publication Date:
- 2018-05
- Subjects:
- angiotensin II -- microRNAs -- smooth muscle cell -- thoracic aortic aneurysm and dissection -- transforming growth factors-β
Arteriosclerosis -- Periodicals
Thrombosis -- Periodicals
Blood-vessels -- Pathophysiology -- Periodicals
Electronic journals
616.13 - Journal URLs:
- http://atvb.ahajournals.org/contents-by-date.0.shtml ↗
http://journals.lww.com ↗ - DOI:
- 10.1161/ATVBAHA.117.310694 ↗
- Languages:
- English
- ISSNs:
- 1079-5642
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1733.670000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 10439.xml